Securities code: Yifan Pharmaceutical Co.Ltd(002019) securities abbreviation: Yifan Pharmaceutical Co.Ltd(002019) Announcement No.: 2022041 Yifan Pharmaceutical Co.Ltd(002019)
Announcement on the election of employee representative supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Yifan Pharmaceutical Co.Ltd(002019) (hereinafter referred to as “the company”) the term of office of the seventh board of supervisors is about to expire. In order to ensure the normal operation of the board of supervisors of the company, in accordance with the company law of the people’s Republic of China and other relevant laws, regulations and normative documents and the relevant provisions of the articles of association, the board of supervisors of the company is composed of three supervisors, one of whom is the employee representative supervisor, elected by the employee congress of the company.
On April 11, 2022, the company held a staff representative meeting in the company’s conference room. After careful deliberation by the staff representatives attending the meeting, the following resolution was unanimously adopted by means of communication voting: elect Mr. Wang Jun as the staff representative supervisor of the eighth board of supervisors of the company (the resume is attached).
Mr. Wang Jun and two non employee representative supervisors elected by the general meeting of the company will jointly form the eighth board of supervisors of the company. The term of office starts from the date of deliberation and approval by the general meeting of shareholders to the date of expiration of the eighth board of supervisors.
The election and post of the above-mentioned staff representatives and supervisors shall meet the requirements of the company law, the articles of association and other laws, regulations and relevant provisions.
After the election of the supervisors of the eighth board of supervisors of the company, there is no situation that the directors, senior managers and their spouses and immediate family members of the company serve as the supervisors of the company during the term of office of the directors and senior managers of the company.
It is hereby announced.
Yifan Pharmaceutical Co.Ltd(002019) board of supervisors April 13, 2022
Resume of employee supervisor representative:
Mr. Wang Jun
Chinese nationality, born in February 1972, Han nationality, professor level senior engineer. From March 2018 to now, he has served as the employee representative supervisor of the company, and from April 2016 to now, he has served as the deputy general manager of Hangzhou Xinfu Technology Co., Ltd. He once served as the manager and deputy general manager of the company’s R & D department and the general manager of biochemical branch of Hangzhou Xinfu Pharmaceutical Co., Ltd. Holding 100 shares of the company’s shares has not been punished by the CSRC and other relevant departments or the stock exchange, nor is it a dishonest executee announced by the Supreme People’s court, and there is no association relationship with shareholders holding more than 5% of the company, controlling shareholders, actual controllers and other directors, supervisors and senior managers of the company, nor does there exist the company law Circumstances stipulated in the articles of association that the company is not allowed to serve as the supervisor of the company.
